Form 4: Dayforce EVP Christopher Armstrong Executes Stock Sales and Option Exercise Under 10b5-1 Plan
SEC Form 4
Dayforce's EVP, Christopher R. Armstrong, reported the sale of common stock and exercise of options on March 22, 2024, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- Christopher R. Armstrong, EVP and Chief Operating Officer of Dayforce, Inc., reported transactions involving the company's stock on March 22, 2024.
- Armstrong sold a total of 59,000 shares of common stock at prices ranging from $68.88 to $70.82.
- These sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on September 19, 2023.
- Armstrong also exercised options to acquire 50,000 shares of common stock at an exercise price of $44.91.
- Following these transactions, Armstrong directly owns 149,319 shares of common stock and holds derivative securities including options and performance units.
- The performance units represent the contingent right to receive shares of common stock based on the achievement of certain performance metrics.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the transactions are part of a pre-planned trading strategy and do not necessarily indicate a change in the executive's outlook on the company.
Future Outlook
The reporting person holds a significant number of performance units that will vest based on the company's performance over the next several years.
Industry Context
Executive stock transactions are common and closely monitored, providing insights into management's perspective on the company's valuation and future prospects.
Comparison to Industry Standards
- Executive compensation packages often include stock options and performance-based equity awards to align management's interests with those of shareholders.
- Rule 10b5-1 plans are a standard practice for corporate insiders to sell shares while avoiding accusations of insider trading.
- Comparable companies in the software and technology sector also utilize similar equity compensation strategies.
Stakeholder Impact
- The stock sales may have a minor impact on the stock price in the short term.
- The vesting of performance units is tied to the company's performance, aligning management's interests with shareholders.
Key Dates
| Date | Description |
|---|---|
| 2023-09-19 | Date of adoption of Rule 10b5-1 trading plan. |
| 2024-03-01 | Date of grant of restricted stock units (RSUs). |
| 2024-03-22 | Date of stock sales and option exercise. |
| 2024-03-26 | Date of signature of the Form 4 filing. |
| 2025-02-24 | Vesting date of 7,059 shares of common stock issuable pursuant to restricted stock units (RSUs). |
| 2025-02-28 | Vesting date of 9,141 shares of common stock issuable pursuant to restricted stock units (RSUs). |
| 2025-03-01 | Vesting date of 12,210 shares of common stock issuable pursuant to restricted stock units (RSUs). |
| 2026-02-28 | Vesting date of 9,141 shares of common stock issuable pursuant to restricted stock units (RSUs). |
| 2027-03-01 | Vesting date of 12,210 shares of common stock issuable pursuant to restricted stock units (RSUs). |
| 2029-02-08 | Expiration date of options. |
| 2030-05-08 | Expiration date of options. |
| 2032-02-24 | Vesting date of performance stock units (PSUs). |
| 2033-02-28 | Vesting date of performance stock units (PSUs). |
| 2034-03-01 | Vesting date of performance stock units (PSUs). |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.